MSD’s CAPVAXIVE vaccine shows promise in pneumococcal disease trial
MSD’s CAPVAXIVE vaccine has demonstrated promising results from the STRIDE-8 Phase III trial, which showed positive immune responses in adults…
All articles by Tiash saha
Tiash saha
-
-
Genprex advances to highest dose in Phase I Acclaim-3 trial of Reqorsa
US-based Genprex has received approval from the Safety Review Committee (SRC) to proceed to the highest dose group of 0.12mg/kg…
-
Anixa Biosciences administers second CAR-T dose in ovarian cancer trial
Anixa Biosciences has administered the second dose of its chimeric antigen receptor T-cell (CAR-T) therapy to a patient in a…